baber/WOPTO huggingface dataset:
Patent FI-830149-A0 (FI)
Inventor: MYLLNER JOSEF
IPC: B31B50/86
Filed: 1983-01-17
Abstract: The gap between the pointed edge and the tangential line of the fourdrinier from the guide roller is a max. of 0.2 times the dia. of the guide roller. - The guide roller has a facility to extract water from the fourdrinier, collected during the operation of the papermaking machine. The design allows the guide roller to extract and evacuate water effectively in a high speed papermaking machine.
Patent FI-833054-A0 (FI)
Inventor: HINDEN JEAN MARCEL
IPC: C25B11/08
Filed: 1983-08-26
Abstract: PCT No. PCT/US81/01763 Sec. 371 Date Aug. 26, 1983 Sec. 102(e) Date Aug. 26, 1983 PCT Filed Dec. 28, 1981 PCT Pub. No. WO83/02288 PCT Pub. Date Jul. 7, 1983.An electrode, especially for chlorine and hypochlorite production, comprises an electrocatalyst consisting of 22-55 mol % ruthenium oxide, 0.2-22 mol % palladium oxide and 44-77.8 mol % titanium oxide. The electrocatalyst may form a coating on a valve metal substrate and may be topcoated with a porous layer of titanium or tantalum oxide.
Patent FI-852958-A0 (FI)
Inventor: BOECKX GUSTAAF M
IPC: C07C271/20
Filed: 1985-07-31
Abstract: Novel  alpha -aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetontr iles which are effective in destruting and/or preventing the growth of Protozoa; pharmaceutical compositions comprising such compounds as active ingredients and processes of preparing such compounds and pharmaceutical compositions.
Patent FI-860821-A0 (FI)
Inventor: FELDMANN HANSUELI
IPC: B62D1/24
Filed: 1986-02-26
Abstract: The collision protection device comprises a collision protector held in a rest position by spring force. Upon collision against an obstacle, the collision protector is displaced against the spring force and thus cooperates with a de-energizing device. This collision protector is mounted on the vehicle chassis by two swing arms arranged symmetrically non-parallel or in angled relationship to the longitudinal axis of the vehicle. This is to permit the de-energizing device to function effectively, irrespective of the place of impact of the obstacle against the collision protector and irrespective of any deformation of the collision protector. Each swing arm is pivotably mounted on the collision protector and on a sliding link member. Each sliding link member is acted upon by the spring force and is displaceably positioned on a cross-shaft mounted on the vehicle chassis perpendicular to the longitudinal axis of the vehicle. Each sliding link member cooperates with the de-energizing device by means of a switching cam or ramp surface when displaced against the spring force. Two flexible retaining elements which may comprise cables or bands connect the collision protector with the vehicle chassis. These cables or bands are arranged at or adjacent the sides of the vehicle and symmetrically to the longitudinal axis of such vehicle.
Patent FI-870067-A0 (FI)
Inventor: KINAST GUENTHER
IPC: A61K31/44
Filed: 1987-01-08
Abstract: Circulation active, e.g. antihypertensive novel methionine-substituted dihydropyridines of the formula   <IMAGE>   in which R1 is phenyl or a heterocyclic radical, or a physiologically acceptable salt thereof.
Patent FI-883862-A0 (FI)
Inventor: WHITE NICHOLAS JOHN
IPC: C07D251/22
Filed: 1988-08-19
Abstract: A radiation sensitive compound is a trimer of <CHEM>  or has the formula <CHEM> wherein R<1> and R<2>, are alkyl, aryl, X, CHX2, CH2X, CX3 or NHR<3> wherein R<3> represents hydrogen, lower alkyl, aryl or @ A<2>,    R<4> represents NCO or R<2> provided that R<3> is not @ - A<2>,   and provided at least one of R<1>, and R<2> and R<4> is CX3, X is halogen, and A<1> and A<2> are each residues of A<1>-H and A<2>-H respectively wherein A<1>-H and A<2>-H are each compounds containing at least one group having an active hydrogen atom. The compounds are useful as initiators and colour change indicators in radiation sensitive compositions for lithographic printing plate production.
Patent FI-894127-A0 (FI)
Inventor: KLEINSTUECK ROLAND
IPC: C07F9/38
Filed: 1989-09-01
Abstract: This invention relates to an improved process for the continuous production of 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTC) and alkali metal salts thereof, in which dialkylphosphite, and ethene-1,2-dicarboxylic acid dialkyl ester, are reacted in the presence of a basic catalyst to form phosphonosuccinic acid tetraalkyl ester, the ester thus obtained is directly reacted with alkyl-acrylate, in the presence of an alkaline catalyst and the reaction product thus obtained is directly hydrolyzed to PBTC or alkali metal salts thereof.
Patent FI-900759-A0 (FI)
Inventor: RABIN DANIEL
IPC: C12P21/02
Filed: 1990-02-15
Abstract: Pancreatic islet cell antigens (ICA) that bind with antibodies found in the sera of patients afflicted with insulin-dependent (Type I) diabetes mellitus (IDDM). ICA proteins are expressed by recombinant cloning vehicles comprising DNA inserts isolated from islet cells. Full sequence native ICA proteins, or protein or peptide fragments thereof, can be used in the diagnosis of IDDM and in detecting or blocking human immunoglobulin, T-cells, or B-cells involved in IDDM.
Patent FI-915968-A0 (FI)
Inventor: MATSUMOTO AKIO
IPC: C08J9/26
Filed: 1991-12-18
Abstract: A method of producing a porous material having open pores comprises stirring a mixture comprising (i) an epoxy compound having at least one epoxy ring in a molecule, (ii) a hardener capable of reacting with the epoxy compount to harden the epoxy compound, (iii) a filler and (iv) water to form an emulsion slurry having a low viscosity and containing the soluble salts uniformly dispersed therein, casting the resulting emulsion slurry in a water impermeable mold and then hardening the slurry while maintaining the water content thereof, and wherein the soluble salts are added to the mixture. The method makes it possible to produce a large scale porous material having open pores and a complicated shape whose shrinkage factor during hardening and water and air permeabilities are controlled to desired levels respectively while scattering thereof is reduced. <IMAGE>
Patent FI-923732-A0 (FI)
Inventor: KARILAINEN JARMO
IPC: B65G11/14
Filed: 1992-08-20
Abstract: A discharge chute especially for use in connection with a concrete carrying mixer, such as a rotating container or a like mounted on the chassis of a truck. The discharge chute (1) includes at least two substantially overlapping chute sections (1a, 1b, 1c) movable relative to each other in the longitudinal direction (s) of discharge chute (1) preferably by means of hydraulic drive mechanisms or the like. Each chute section (1a, 1b, 1c) includes an intermediate portion (a), comprising a discharge through, and edge portions (b) which are fitted with a slide-support assembly for enabling the relative movement of overlapping chute sections and for bracing the same together. The edge portions (b', b") of chute sections (1a, 1b, 1c) of discharge chute (1) are essentially identically shaped in cross section and thus adapted to be overlapped on each other and, thus, being spaced a distance from each other, essentially form said slide-support assembly.
Patent FI-923811-A0 (FI)
Inventor: LEE CHONG U
IPC: H04N7/30
Filed: 1992-08-25
Abstract: An image compression system and method for compressing image data for transmission. Each block and corresponding sub-blocks of pixel data is subjected to a discrete cosine transform (DCT) operation. Varying levels of sub-blocks of resulting corresponding transform coefficients are selected for construction into a composite transform coefficient block corresponding to each input block of pixel data. The selection of transform coefficient block size for the composite block is determined by a comparison process between transform block and sub-block coding efficiency. The composite block is variable length coded to further reduce bit count in the compressed data.
Patent FI-933519-A0 (FI)
Inventor: GOTTSCHALK MICHAEL
IPC: C12N15/75
Filed: 1993-08-10
Abstract: A novel xylanase, obtained from Bacillus subtilis strains, is provided which improves the consistency and increases the volume of bread and baked goods containing it. B. subtilis DSM 7147 containing the plasmid pIK 91 produces the xylanase. Genetic engineering insertion of the gene encoding the xylanase in the plasmid pUB110 is described.
Patent FI-956361-A0 (FI)
Inventor: KORVENHEIMO PETTERI
IPC: H04B1/036
Filed: 1995-12-29
Abstract: A method and arrangement for cooling an apparatus cabinet by: causing air to flow into a cooling arrangement that is connected to the cabinet to remove heat from the cabinet and to produce an exhaust flow of air that is heated by the heat removed from the cabinet; and reducing noise produced by the exhaust flow by conveying the exhaust flow to a space outside of the cabinet through a separate mounting base disposed beneath the cabinet.
Patent FI-963696-A0 (FI)
Inventor: BROWN THOMSEN JOHN
IPC: A61K8/34
Filed: 1996-09-18
Abstract: Gel for local treatment of skin diseases and for prophylaxis, characterized by containing more than 90% of a drying and/or protein coagulating, short-chained alcohol or alcohol mixture, primarily ethanol, and possibly adjuvants or additives and by containing a gelling agent, that possesses good skin-adhesive properties, that gives a matrix formation of alcohol or alcohol mixtures, that creates an evaporation inhibiting effect, gives a prolonged effect, and form a protective plaster when the gel has dried.
Patent FI-965137-A0 (FI)
Inventor: PELTONEN KARI
IPC: B01F27/96
Filed: 1996-12-20
Abstract: The present invention relates to a method and a device for mixing a second medium into a first medium. The method and the device according to the invention are particularly advantageous when used for mixing different chemicals, both liquid and gaseous, or steam into pulp suspension in the wood processing industry. In the method and device according to the invention, the first medium is fed into the mixer housing (10), mixed therein and removed from said housing (10), a freely rotatable rotor (20) being placed in said housing (10) and turned by means of the incoming medium flow into the housing (10).
Patent FI-990270-A0 (FI)
Inventor: DALEN ARE
IPC: A61K31/7072
Filed: 1999-02-10
Abstract: Fatty acid esters (I) of nucleosides or nucleoside analogues are new, where the fatty acid is a monounsatd. 18 to 20C fatty acid esterified with the 5'-OH gp. of nucleosides or with an OH gp. on the noncyclic chain of nucleoside analogues. (I) have higher activity than the parent nucleosides or analogues and have relatively low toxicity. Pref., (I) are esters of acyclovir, Ara T, Ara A or AZT with oleic acid, elaidic acid or cis- or trans-eicosenic acid.
Patent IL-78173-A0 (IL)
Title: Preparation of the(-)-antipode of(e)-1-cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-penti-1-ene
IPC: C07D521/00
Filed: 1986-03-17
Abstract: A process for the preparation of the (-)-antipode of (E)-1-cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ene of the formula   <IMAGE>   which comprises reacting the (E)-isomer of 1-cyclohexyl-4,4-dimethyl-2-(1,2,4-triazol-1-yl)-pent-1-en-3-one of the formula   <IMAGE>  with lithium aluminum hydride in the presence of an inert organic diluent and in the presence of a chiral aminoalcohol at a temperature between -70 DEG  C. and +50 DEG  C. The (-)-antipode is produced in high selectivity, using (-)-N-methyl-ephedrine.
Patent IL-85346-A0 (IL)
Title: Pharmaceutical compositions containing human blood coagulation factor xiii
IPC: A61K35/14
Filed: 1988-02-08
Abstract: The use of human blood coagulation factor XIII for the treatment of ulcerative colitis is demonstrated in 4 representative cases. Treatment with factor XIII leads to rapid and total disappearance of the chief symptoms realizing transition to the remission stage.
Patent IL-93401-A0 (IL)
Title: 1,7-fused 1h-indole-2-carboxylic acid n-(1,4-benzodiazepin-3-yl)amides,their preparation and medicaments comprising them
IPC: C07D498/06
Filed: 1990-02-14
Abstract: Compounds corresponding to the formula I   <IMAGE> (I)  in which R1 represents hydrogen, lower alkyl or cycloalkylalkyl with 4-7 carbon atoms, R2 represents hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl, and R3 represents hydrogen, halogen, lower alkyl or lower alkoxy, or R2 and R3 together denote an alkylenedioxy group, R4 represents cycloalkyl with 5 to 6 carbon atoms, thiophene or optionally substituted phenyl, R5 represents hydrogen or halogen, R6 represents hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl, and Z represents an alkylene chain with 2-4 carbon atoms, which can optionally be mono- or disubstituted by lower alkyl or onto which a 5-6-membered carbocyclic ring can optionally be fused, or represents an -X-CH2-CH2- chain, which have pharmacologically valuable properties, are described, together with a method for their preparation.
Patent FI-20021668-A0 (FI)
Inventor: MIKKOLA JYRKI
IPC: H01Q5/371
Filed: 2002-09-19
Abstract: An internal planar antenna for small radio apparatuses, and a radio apparatus. The ground plane (310) of the planar antenna is shaped such that it improves the matching of the antenna. The shaping may be done by means of one or more slots (315, 316) in the ground plane. The slot suitably changes the electrical length of the ground plane as viewed from the short-circuit point (S) so that the ground plane will function as a radiator in an operating band of the antenna. Also the slot (331) in the ground plane can be arranged to function as an additional radiator in an operating band of the antenna. Antenna gain will increase as the matching is improved, and the upper band of a dual band antenna, for example, can be made broader. Alternatively, the antenna can be fabricated flatter without degrading the electrical characteristics. <IMAGE>
Patent FI-20030622-A0 (FI)
Inventor: SKWAREK JAROSLAW
IPC: H04L29/08
Filed: 2003-04-24
Abstract: The method involves using directed relations representing an operation related to service, connecting one node representing input parameter to another node representing output parameter, to create a data model. Independent claims are also included for the following: (1) method for analyzing data model; (2) method for analyzing operations related to services; (3) computer program for creating data model; (4) computer for creating data model; and (5) computer for analyzing operations related to service.
Patent IL-108133-A0 (IL)
Title: Motor-vehicle parking system
IPC: E04H6/28
Filed: 1993-12-22
Abstract: A system for parking motor vehicles exhibits one or more autonomous parking units (S) which are, in outline, in the form of a sector of a circle. Each unit of this kind is assigned a vehicle lift (10), as mechanical conveying means, having a vertical guide (11) arranged in the region of the vertex of the sector and having a projecting vehicle platform (12) which can pivot over the angle of the sector. The task of the lift (10), within the parking unit (S), is to transport the vehicles vertically and horizontally between an entrance/exit level (1) and parking bays which are located on parking levels beneath and/or above the level (1); the lift (10) is further set up for the radial shifting of the vehicles. Each parking unit (S) is, moreover, assigned means for turning in each case one vehicle on the spot, e.g. one or more rotary platforms (8) on the entrance/exit level (1). The vehicle standing surface (9) of each rotary platform can be optionally lined up in an entrance position, an exit position or such that it is radially aligned with the vehicle platform (12) of the lift. A facility of this type adapts (computer-controlled) very flexibly to various operating situations. When driving out, the vehicles can leave the facility such that they can drive forwards straight away. By virtue of a modular construction method, it is not only round facilities which can be produced, but - always having the same units (S) - also other facility outlines which are adapted to the relevant situation. <IMAGE>
Patent IL-117927-A0 (IL)
Title: Antiarrhythmic and cardioprotective substituted indenoylguanidines
IPC: C07C327/54
Filed: 1996-04-16
Abstract: Indenoylguanidines of formula I, the process for their preparation, their use as medicaments, medicaments containing them, their use as diagnostic agents and medicaments containing them are described. Compounds I are useful for treating cardiac arrhythmias. Further they are useful as cardioprotective agents in mammals, which comprises administering the compound of formula-I with the above properties in combination with pharmaceutically accepted carrier to said mammal. <CHEM>
Patent IL-121125-A0 (IL)
Title: Mercaptoketones and mercaptoalcohols and their preparation
IPC: C07D307/33
Filed: 1997-06-20
Abstract: This invention relates to matrix metalloproteinase (MMP) inhibiting compounds of the formula: <CHEM> where R<1> is C1-C12 alkyl, straight or branched and optionally substituted by halogen, hydroxy, C1-C6 alkoxy, amino, carboxyl, C1-C6 alkoxycarbonyl, carboxamido, nitrile, mono- or di-(C1-C6)alkylamino, thio, C1-C6 alkylthio, aryl, -Oaryl or -OCH2aryl where aryl is optionally substituted with C1-C6 alkyl, C1-C6 alkoxy, carboxy, halogen, cyano, nitro, carboxamido, or hydroxy; and C1-C6 alkanesulfonyloxy. R<2> is  alpha -OH or  beta -OH and R<6> is H or R<2> and R<6> together are carbonyl; the chemical intermediates; and processes for the preparation of these compounds and the intermediates thereto. Matrix metalloproteinases (MMP) are a family of zinc-containing calcium dependent proteinases, including stromelysins, collagenases, and gelatinases. These MMP enzymes are capable of degrading the proteinaceous components of connective tissue and appear to be involved in tissue remodeling, i.e., wound healing and connective tissue turnover. Unexpectedly, the mercaptoalcohols with the S-configuration at the hydroxyl-bearing carbon have been found to be at least 4 times more potent than the analogous (R)-alcohols both in vitro and in vivo in inhibiting the MMP enzyme..
Patent IL-122098-A0 (IL)
Title: Vinylpyrrolidinon cephalosplorin derivatives their preparation and pharmaceutical compositions containing them
IPC: C07D501/54
Filed: 1997-11-04
Abstract: The present invention relates to cephalosporin derivatives of the general formula <CHEM>  where   R<1>   is halogen, lower alkyl, phenyl, benzyl, styryl, naphthyl or heterocyclyl; the lower alkyl, phenyl, benzyl, styryl, naphthyl and heterocyclyl being optionally substituted by at least one of halogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkoxy, optionally substituted phenyl, amino, lower alkylamino, di-lower alkylamino, carboxy, lower alkylcarboxy, carbamoyl or lower alkylcarbamoyl; R<4>, R<5>   independently are hydrogen, lower alkyl or phenyl; X   is S, O, NH or CH2; n   is 0,1 or 2; m   is 0 or 1; s   is 0 or 1; R<2>   is hydrogen, hydroxy, -CH2-CONHR<6>, lower alkyl-Qr, cycloalkyl-Qr, lower alkoxy, lower alkenyl, cycloalkenyl-Qr, lower alkynyl, aralkyl-Qr, aryl-Qr, aryloxy, aralkoxy, a heterocyclic ring or a heterocyclyl-Qr, the lower alkyl, cycloalkyl, lower alkoxy, lower alkenyl, cycloalkenyl, lower alkynyl, aralkyl, aryl, aryloxy, aralkoxy and the heterocyclic ring may be substituted with at least one group selected from carboxy, amino, nitro, cyano, -SO2NHR<6>, optionally fluoro substituted lower alkyl, lower alkoxy, hydroxy, halogen, -CONR<6>R<7>, -CH2CONR<6>R<7>, -N(R<7>)COOR<8>, R<7>CO-, R<7>OCO-, R<7>COO-, -C(R<7>R<9>)CO2R<8>, -C(R<7>R<9>)CONR<7>R<10>, wherein     R<6> is hydrogen, lower alkyl, cycloalkyl or aryl;   R<7> and R<9> are independently hydrogen or lower alkyl; R<8> is hydrogen, lower alkyl, lower alkenyl or a carboxylic acid protecting group; and R<10> is hydrogen,  omega -hydroxy-alkyl, phenyl, naphthyl or heterocyclyl, the phenyl, naphthyl or heterocyclyl being unsubstituted or substituted with at least one of the groups of optionally protected hydroxy, halogen, optionally substituted lower alkyl or  omega -hydroxyalkyl, optionally substituted lower alkoxy and/or cyano, or R<7> and R<10> form together group of formula <CHEM>     Q   is -CHR-, -CO- or -SO2-; r   is 0 or 1; R   is hydrogen or lower alkyl; and R<3>   is hydroxy, -O<->, lower-alkoxy, or -OM and M represents an alkali metal; as well as readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts, as wen as the preparation of such compounds, their use for the treatment of infectious diseases and pharmaceutical preparations containing such compounds.
Patent IL-132522-A0 (IL)
Title: Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and pharmaceutical compositions containing the same
IPC: A61K31/44
Filed: 1998-04-22
Abstract: This invention is related to carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones represented by Formula I:or a pharmaceutically acceptable salt or prodrug thereof, wherein:Y is oxygen or sulfur; R1, R21, R22 and R23 are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, haloalkyl, aryl, aminoalkyl, hydroxyalkyl, alkoxyalkyl or carboxyalkyl; or R22 and R23, together with the N, form a heterocycle; A1 and A2 are independently aryl, heteroaryl, saturated or partially unsaturated carbocycle or saturated or partially unsaturated heterocycle, any of which is optionally substituted; X is one or O, S, NR24, CR25R26, C(O), NR24C(O), C(O)NR24, SO, SO2 or a covalent bond; where R24, R25 and R26 are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, haloalkyl, aryl, aminoalkyl, hydroxyalkyl, alkoxyalkyl or carboxyalkyl. The invention also is directed to the use of carbocycle and heterocycle substituted semicarbazones and thiosemicarbazones for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), for the treatment and prevention of otoneurotoxicity and eye diseases involving glutamate toxicity and for the treatment, prevention or amelioration of pain, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy and urinary incontinence.
Patent IL-132578-A0 (IL)
Title: Method and device for gluing two substrates
IPC: B32B37/00
Filed: 1998-04-02
Abstract: This novel method adheres two substrates (3, 6) together, forming a disc (23). This product is especially a digital video disk (DVD). Adhesive is coated onto a surface of the first substrate (3), and the second substrate (6) is laid upon it. Specific sides are joined together in this way. The novel feature of this process, is that the combined substrates are rotated about their central axis, to eject adhesive. Also claimed is the corresponding equipment.
Patent IL-143344-A0 (IL)
Title: Milling process for the production of finely milled medicinal substances
IPC: A61K9/14
Filed: 1999-12-01
Abstract: The invention is an improved method of generating fine medicament powders suitable for inhalation. A fluid energy mill is used with conventional milling fluids such as air or nitrogen. The milling fluid is treated to have a controlled relative humidity of between 30% and 70%. This produces a fine medicament powder with a median particle size below 10 micrometer but with little or no amorphous content generated during milling. Scale formation in the mill chamber is also greatly reduced.